Cargando…

Diffuse myocardial fibrosis by post-contrast T1-time predicts outcome in heart failure with preserved ejection fraction

Detalles Bibliográficos
Autores principales:	Marzluf, Beatrice A, Bonderman, Diana, Tufaro, Caroline, Pfaffenberger, Stefan, Graf, Alexandra, Hülsmann, Martin, Lang, Irene M, Pacher, Richard, Maurer, Gerald, Mascherbauer, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Moderated Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559521/ http://dx.doi.org/10.1186/1532-429X-15-S1-M6

Ejemplares similares

Epicardial fat volume is inversely correlated with the degree of diastolic dysfunction and outcome in patients with heart failure with preserved ejection fraction
por: Karakus, Gültekin, et al.
Publicado: (2013)

Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fraction
por: Karakus, Gültekin, et al.
Publicado: (2015)

Gender-related differences in heart failure with preserved ejection fraction
por: Duca, Franz, et al.
Publicado: (2018)

Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance
por: Goliasch, Georg, et al.
Publicado: (2015)

Presence of ´isolated´ tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction
por: Mascherbauer, Julia, et al.
Publicado: (2017)

Extracellular matrix expansion by cardiac magnetic resonance T1 mapping- validation with myocardial biopsy
por: Kammerlander, Andreas, et al.
Publicado: (2015)

Persistent atrial fibrillation in heart failure with preserved ejection fraction: Prognostic relevance and association with clinical, imaging and invasive haemodynamic parameters
por: Schönbauer, Robert, et al.
Publicado: (2019)

Prognostic Impact of Tricuspid Regurgitation in Patients Undergoing Aortic Valve Surgery for Aortic Stenosis
por: Mascherbauer, Julia, et al.
Publicado: (2015)

Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction
por: Dalos, Daniel, et al.
Publicado: (2019)

Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling: Ready for prime time?
por: Kammerlander, Andreas A., et al.
Publicado: (2017)

Cardiovascular magnetic resonance feature tracking in patients with acute myocarditis and normal ejection fraction: potential for improved diagnosis and prognosis
por: Khanji, Mohammed Y, et al.
Publicado: (2015)

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial( )
por: Dachs, Theresa Marie, et al.
Publicado: (2022)

Patients with Heart Failure and Preserved Ejection Fraction Are at Risk of Gastrointestinal Bleeding
por: Schrutka, Lore, et al.
Publicado: (2019)

Fractional Excretion of Sodium and Urea are Useful Tools in the Evaluation of AKI: COMMENTARY
por: Brown, Robert S.
Publicado: (2022)

Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction: Study protocol for a randomized controlled trial
por: Mascherbauer, Julia, et al.
Publicado: (2016)

Prevalence and prognostic significance of right ventricular systolic dysfunction in heart failure with preserved ejection fraction. Insights from a cardiac magnetic resonance imaging study
por: Aschauer, Stefan, et al.
Publicado: (2015)

Extracellular volume assessed by CMR T1-mapping correlates with histologically determined amount of diffuse fibrosis in DCM
por: aus dem Siepen, Fabian, et al.
Publicado: (2014)

Pre- and post-contrast T1 mapping for detection of myocardial fibrosis in severe aortic stenosis before and after aortic valve replacement
por: Vermes, Emmanuelle, et al.
Publicado: (2014)

Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension
por: Patel, Ravi B., et al.
Publicado: (2020)

Effect of contrast dose, post-contrast acquisition time, myocardial regionality, cardiac cycle and gender on dynamic-equilibrium CMR measurement of myocardial extracellular volume
por: Miller, Christopher A, et al.
Publicado: (2013)

Cerebral oxygen delivery in newborns with congenital heart disease by phase contrast MRI
por: Lim, Jessie Mei, et al.
Publicado: (2015)

Heart failure with preserved ejection fraction after left‐sided valve surgery: prevalent and relevant
por: Kammerlander, Andreas A., et al.
Publicado: (2021)

Determination of the volume of coronary microemboli needed for reproducible visualization of microinfarcts on contrast enhanced MDCT and MRI
por: Do, Loi, et al.
Publicado: (2012)

Quantification of aortic pulse wave velocity in preterm infants using 4D phase contrast MRI
por: Broadhouse, Kathryn, et al.
Publicado: (2013)

Myocardial fibrosis is associated with subsequent death and hospitalization for heart failure in obese adults
por: Fridman, Yaron, et al.
Publicado: (2015)

Myocardial T1-mapping for early detection of left ventricular myocardial fibrosis in systemic sclerosis
por: Thuny, Franck, et al.
Publicado: (2011)

Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction
por: Roy, Clotilde, et al.
Publicado: (2018)

High-Cutoff Hemodialysis Therapy for Patients with Light Chain Cast Nephropathy and AKI Requiring Dialysis: Commentary
por: Cosmai, Laura, et al.
Publicado: (2023)

Kidney Biopsy in a Pregnant Patient with Suspected Glomerular Disease: Commentary
por: Hladunewich, Michelle A.
Publicado: (2023)

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
por: Sweeney, Mark, et al.
Publicado: (2020)

Effects of Kangdaxin on myocardial fibrosis in heart failure with preserved ejection fraction rats
por: Wu, Xiang, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death
por: Schrutka, Lore, et al.
Publicado: (2022)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2017)

Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
por: Michalska-Kasiczak, Marta, et al.
Publicado: (2018)

Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction
por: Garg, Pankaj, et al.
Publicado: (2021)

Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction
por: Liu, Xiao, et al.
Publicado: (2022)

Long-Term Outcome of Combined (Percutaneous Intramyocardial and Intracoronary) Application of Autologous Bone Marrow Mononuclear Cells Post Myocardial Infarction: The 5-Year MYSTAR Study
por: Gyöngyösi, Mariann, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_98bpdjbk9aofjvsp0hl3hf545g